Hepion Pharmaceuticals, Inc.
HEPA
$0.3339
$0.036412.24%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 73.04% | 49.18% | 33.57% | 20.63% | -15.94% |
| Total Depreciation and Amortization | -54.10% | -41.20% | -15.03% | 9.90% | -13.31% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -172.83% | -31.81% | -39.90% | -8.58% | 24.70% |
| Change in Net Operating Assets | -190.30% | -169.11% | -352.71% | -120.80% | -5.76% |
| Cash from Operations | 55.45% | 28.95% | 8.42% | -9.82% | -16.95% |
| Capital Expenditure | -- | 99.01% | 107.01% | 12.88% | 12.88% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -4,125.35% | -1,887.75% | 107.01% | -1.43% | -1.43% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -3.23% | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -3.23% | 381.90% | 302.22% | 302.22% | 187.49% |
| Foreign Exchange rate Adjustments | 1,607.84% | 489.66% | 191.44% | 331.01% | 110.81% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 60.50% | 55.38% | 31.03% | 17.50% | 9.35% |